Multifocal Small Bowel Carcinoid Evaluation by 68Ga-DOTATATE PETClark, Michael, MD; Nathan, Mark, MD; Broski, Stephen, MDClinical Nuclear Medicine: April 2019 - Volume 44 - Issue 4 - p e308–e310 doi: 10.1097/RLU.0000000000002487 Interesting Images Buy SDC Abstract Author InformationAuthors Article MetricsMetrics Carcinoid is a subtype of neuroendocrine tumor, a rare group of tumors that are known to express somatostatin receptor 2. 68Ga-DOTATATE is a somatostatin analog that is specific for somatostatin receptor 2 and therefore allows visualization of neuroendocrine tumors. We present 2 cases of primary multifocal small bowel carcinoid evaluated using 68Ga-DOTATATE PET/CT, along with contrast-enhanced CT corollary findings. Given the increased sensitivity of 68Ga-DOTATATE PET/CT compared with CT and 111In-octreotide scintigraphy, we expect multifocal carcinoid to become increasingly recognized. From the Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, Rochester, MN. Received for publication November 21, 2018; revision accepted December 26, 2018. Conflicts of interest and sources of funding: none declared. Correspondence to: Stephen Broski, MD, Department of Radiology, Division of Nuclear Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905. E-mail: Broski.Stephen@mayo.edu. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.